Sema Investment is a venture capital firm based in Seoul, South Korea. Founded in 2015 and established by the Korea Science and Technology Institute, it specializes in investments in public technology companies.
Recl operates a platform that collects and recycles used clothing, enabling a circular economy by refurbishing items and selling them through a used clothing e-commerce channel, including bulk sales, to promote sustainable fashion.
Veluga
Series A in 2023
Veluga is a membership service that delivers curated craft beer selections twice a month, accompanied by complementary snack pairings.
KB-Element
Venture Round in 2023
KB-Element is a company focused on the development and production of graphene and carbon nanotube (CNT) materials. It specializes in creating intermediate items and novel materials for various applications, particularly in the semiconductor and display sectors. The company manufactures a range of products, including anti-static agents, conductive pastes, thermally conductive materials, and electromagnetic shielding solutions. These materials are designed to address challenges related to harmful electromagnetic waves and heat generated in electronic devices, which are increasingly prevalent due to the miniaturization of electronic components. Through its innovative approach, KB-Element aims to provide effective solutions to enhance the performance and reliability of electronic devices.
EGNIS
Series B in 2023
EGNIS is a supplier of food products.
Zero X And
Seed Round in 2023
Zero X And is a developer specializing in blockchain games and services, aimed at creating a decentralized metaverse. The company provides a framework and building blocks for NFT gaming, facilitating the management and exchange of non-fungible tokens within blockchain projects. By offering innovative solutions, Zero X And enables game developers to enhance user engagement and explore new monetization strategies for digital assets. Its focus on integrating blockchain technology with gaming positions it as a significant player in the evolving landscape of digital entertainment.
One Curegen
Series A in 2021
One Curegen develops diagnostic anti-cancer drugs.
Gloud
Gloud offers dental digital and digital practice transformation services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.